Guocoland: CIMB initiates on Guocoland and believes the stock is due for re-rating. The house has a TP of $2.88, based on a 25% discount to its base case RNAV of $3.84.
Securing ownership of the Beijing Dongzhimen (DZM) project would re-focus investors’ attention to the potential value unlocking upside rather than on the drag from possible provision for cost write-offs that had hampered past share price performance.
The group is on track to achieve a more sustainable ROE by expanding recurrent income base from FY17. Room to move up the value chain to fund management exists in mid-term.
Guocoland is trading at a 38% discount to CIMB's base case RNAV of $3.84. There is upside room to Guocoland’s RNAV if Guocoland Malaysia’s share price discount to book NAV narrows or if surplus from DZM is greater than its base case assumptions.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment